222 related articles for article (PubMed ID: 29244610)
1. Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin.
Khan FM; Saleh E; Alawadhi H; Harati R; Zimmermann WH; El-Awady R
Cancer Biol Ther; 2018 Jan; 19(1):25-33. PubMed ID: 29244610
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
Front Immunol; 2021; 12():692654. PubMed ID: 34149737
[TBL] [Abstract][Full Text] [Related]
3. Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone.
Koch R; Aung T; Vogel D; Chapuy B; Wenzel D; Becker S; Sinzig U; Venkataramani V; von Mach T; Jacob R; Truemper L; Wulf GG
Clin Cancer Res; 2016 Jan; 22(2):395-404. PubMed ID: 26369630
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer.
Yang SJ; Wang DD; Li J; Xu HZ; Shen HY; Chen X; Zhou SY; Zhong SL; Zhao JH; Tang JH
Gene; 2017 Aug; 623():5-14. PubMed ID: 28438694
[TBL] [Abstract][Full Text] [Related]
5. REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer.
Kawasaki K; Watanabe M; Sakaguchi M; Ogasawara Y; Ochiai K; Nasu Y; Doihara H; Kashiwakura Y; Huh NH; Kumon H; Date H
Cancer Gene Ther; 2009 Jan; 16(1):65-72. PubMed ID: 18654608
[TBL] [Abstract][Full Text] [Related]
6. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222.
Yu DD; Wu Y; Zhang XH; Lv MM; Chen WX; Chen X; Yang SJ; Shen H; Zhong SL; Tang JH; Zhao JH
Tumour Biol; 2016 Mar; 37(3):3227-35. PubMed ID: 26432333
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin Expands in Vivo Secretion of Circulating Exosome in Mice.
Emam SE; Ando H; Abu Lila AS; Kobayashi S; Shimizu T; Okuhira K; Ishima Y; Ishida T
Biol Pharm Bull; 2018; 41(7):1078-1083. PubMed ID: 29962402
[TBL] [Abstract][Full Text] [Related]
8. Ketotifen reverses MDR1-mediated multidrug resistance in human breast cancer cells in vitro and alleviates cardiotoxicity induced by doxorubicin in vivo.
Zhang Y; Berger SA
Cancer Chemother Pharmacol; 2003 May; 51(5):407-14. PubMed ID: 12687290
[TBL] [Abstract][Full Text] [Related]
9. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
[TBL] [Abstract][Full Text] [Related]
10. Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer.
Wang X; Xu C; Hua Y; Sun L; Cheng K; Jia Z; Han Y; Dong J; Cui Y; Yang Z
J Exp Clin Cancer Res; 2016 Dec; 35(1):186. PubMed ID: 27906043
[TBL] [Abstract][Full Text] [Related]
11. Exosome is a mechanism of intercellular drug transfer: Application of quantitative pharmacology.
Wang J; Yeung BZ; Cui M; Peer CJ; Lu Z; Figg WD; Guillaume Wientjes M; Woo S; Au JL
J Control Release; 2017 Dec; 268():147-158. PubMed ID: 29054369
[TBL] [Abstract][Full Text] [Related]
12. [Extraction and identification of exosomes from drug-resistant breast cancer cells and their potential role in cell-to-cell drug-resistance transfer].
Xu J; Li W; Zhong S; Li X; Chen Z; Hu Q; Tang J; Zhao J
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):165-70. PubMed ID: 24785274
[TBL] [Abstract][Full Text] [Related]
13. Stressors alter intercellular communication and exosome profile of nasopharyngeal carcinoma cells.
Harmati M; Tarnai Z; Decsi G; Kormondi S; Szegletes Z; Janovak L; Dekany I; Saydam O; Gyukity-Sebestyen E; Dobra G; Nagy I; Nagy K; Buzas K
J Oral Pathol Med; 2017 Apr; 46(4):259-266. PubMed ID: 27598726
[TBL] [Abstract][Full Text] [Related]
14. An ROS-responsive and self-accelerating drug release nanoplatform for overcoming multidrug resistance.
Lv X; Zhu Y; Ghandehari H; Yu A; Wang Y
Chem Commun (Camb); 2019 Mar; 55(23):3383-3386. PubMed ID: 30821310
[TBL] [Abstract][Full Text] [Related]
15. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
[TBL] [Abstract][Full Text] [Related]
16. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
[TBL] [Abstract][Full Text] [Related]
17. Dual function of programmed cell death 10 (PDCD10) in drug resistance.
Urfali-Mamatoglu C; Kazan HH; Gündüz U
Biomed Pharmacother; 2018 May; 101():129-136. PubMed ID: 29482058
[TBL] [Abstract][Full Text] [Related]
18. Exosomal CircPRRX1 Enhances Doxorubicin Resistance in Gastric Cancer by Regulating MiR-3064-5p/PTPN14 Signaling.
Wang S; Ping M; Song B; Guo Y; Li Y; Jia J
Yonsei Med J; 2020 Sep; 61(9):750-761. PubMed ID: 32882759
[TBL] [Abstract][Full Text] [Related]
19. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
[TBL] [Abstract][Full Text] [Related]
20. In situ Fourier transform infrared analysis of live cells' response to doxorubicin.
Fale PL; Altharawi A; Chan KL
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2640-8. PubMed ID: 26231933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
